<DOC>
	<DOC>NCT00090363</DOC>
	<brief_summary>This study is being carried out to see if ZD4054 (Zibotentan) is effective in treating prostate cancer and spread of cancer to the bone, and if so, how it compares with placebo (sugar pill). The study will also provide further information on the safety of ZD4054 (Zibotentan).</brief_summary>
	<brief_title>ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Surgically or medically castrated Bone metastasis Rising PSA Opiate use Prior chemotherapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>rising PSA</keyword>
	<keyword>bone metastases</keyword>
	<keyword>Clinical study</keyword>
	<keyword>pain-free or mildly symptomatic</keyword>
</DOC>